These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7802626)

  • 1. Identification of functional domains in AMPD1 by mutational analysis.
    Gross M; Morisaki H; Morisaki T; Holmes EW
    Biochem Biophys Res Commun; 1994 Dec; 205(2):1010-7. PubMed ID: 7802626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of N-terminal sequences in human AMP deaminase isoforms that influence contractile protein binding.
    Mahnke-Zizelman DK; Sabina RL
    Biochem Biophys Res Commun; 2001 Jul; 285(2):489-95. PubMed ID: 11444869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of AMP deaminase 1 binding to myosin heavy chain.
    Hisatome I; Morisaki T; Kamma H; Sugama T; Morisaki H; Ohtahara A; Holmes EW
    Am J Physiol; 1998 Sep; 275(3):C870-81. PubMed ID: 9730972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divergent N-terminal regions in AMP deaminase and isoform-specific catalytic properties of the enzyme.
    Bausch-Jurken MT; Sabina RL
    Arch Biochem Biophys; 1995 Aug; 321(2):372-80. PubMed ID: 7646062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a conserved motif that is necessary for binding of the vaccinia virus E3L gene products to double-stranded RNA.
    Chang HW; Jacobs BL
    Virology; 1993 Jun; 194(2):537-47. PubMed ID: 8099244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subunit composition of AMPD varies in response to changes in AMPD1 and AMPD3 gene expression in skeletal muscle.
    Fortuin FD; Morisaki T; Holmes EW
    Proc Assoc Am Physicians; 1996 Jul; 108(4):329-33. PubMed ID: 8863347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization and expression patterns of AMP deaminase1 (AMPD1) in porcine skeletal muscle.
    Wang L; Mo X; Xu Y; Zuo B; Lei M; Li F; Jiang S; Deng C; Xiong Y
    Comp Biochem Physiol B Biochem Mol Biol; 2008 Oct; 151(2):159-66. PubMed ID: 18638563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myoadenylate deaminase deficiency caused by alternative splicing due to a novel intronic mutation in the AMPD1 gene.
    Isackson PJ; Bujnicki H; Harding CO; Vladutiu GD
    Mol Genet Metab; 2005; 86(1-2):250-6. PubMed ID: 16040263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and functional analysis of the p42Ets-1 variant of the mouse Ets-1 transcription factor.
    Lionneton F; Lelièvre E; Baillat D; Stehelin D; Soncin F
    Oncogene; 2003 Dec; 22(57):9156-64. PubMed ID: 14668797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferation-associated SNF2-like gene (PASG): a SNF2 family member altered in leukemia.
    Lee DW; Zhang K; Ning ZQ; Raabe EH; Tintner S; Wieland R; Wilkins BJ; Kim JM; Blough RI; Arceci RJ
    Cancer Res; 2000 Jul; 60(13):3612-22. PubMed ID: 10910076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning of human AMP deaminase isoform E cDNAs. Evidence for a third AMPD gene exhibiting alternatively spliced 5'-exons.
    Mahnke-Zizelman DK; Sabina RL
    J Biol Chem; 1992 Oct; 267(29):20866-77. PubMed ID: 1400401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel pathway for alternative splicing: identification of an RNA intermediate that generates an alternative 5' splice donor site not present in the primary transcript of AMPD1.
    Mineo I; Clarke PR; Sabina RL; Holmes EW
    Mol Cell Biol; 1990 Oct; 10(10):5271-8. PubMed ID: 2398891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human Nramp2 gene: characterization of the gene structure, alternative splicing, promoter region and polymorphisms.
    Lee PL; Gelbart T; West C; Halloran C; Beutler E
    Blood Cells Mol Dis; 1998 Jun; 24(2):199-215. PubMed ID: 9642100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the HPRG Component of Striated Muscle AMP Deaminase in the Stability and Cellular Behaviour of the Enzyme.
    Ronca F; Raggi A
    Biomolecules; 2018 Aug; 8(3):. PubMed ID: 30142952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of filamin A with the integrin beta 7 cytoplasmic domain: role of alternative splicing and phosphorylation.
    Travis MA; van der Flier A; Kammerer RA; Mould AP; Sonnenberg A; Humphries MJ
    FEBS Lett; 2004 Jul; 569(1-3):185-90. PubMed ID: 15225631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of rat AMP deaminase 3 (isoform C) by development and skeletal muscle fibre type.
    Mahnke-Zizelman DK; D'cunha J; Wojnar JM; Brogley MA; Sabina RL
    Biochem J; 1997 Sep; 326 ( Pt 2)(Pt 2):521-9. PubMed ID: 9291127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative splicing: a mechanism for phenotypic rescue of a common inherited defect.
    Morisaki H; Morisaki T; Newby LK; Holmes EW
    J Clin Invest; 1993 May; 91(5):2275-80. PubMed ID: 8486786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contributions of multiple basic amino acids in the C-terminal region of yeast ribosomal protein L1 to 5 S rRNA binding and 60 S ribosome stability.
    Yeh LC; Lee JC
    J Mol Biol; 1995 Feb; 246(2):295-307. PubMed ID: 7869381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel aspects of tetramer assembly and N-terminal domain structure and function are revealed by recombinant expression of human AMP deaminase isoforms.
    Mahnke-Zizelman DK; Tullson PC; Sabina RL
    J Biol Chem; 1998 Dec; 273(52):35118-25. PubMed ID: 9857047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards an understanding of the functional significance of N-terminal domain divergence in human AMP deaminase isoforms.
    Sabina RL; Mahnke-Zizelman DK
    Pharmacol Ther; 2000; 87(2-3):279-83. PubMed ID: 11008004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.